Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
1.500
-0.060 (-3.85%)
Nov 21, 2024, 11:08 AM EST - Market open
Cellectar Biosciences Market Cap
Cellectar Biosciences has a market cap or net worth of $53.77 million as of November 21, 2024. Its market cap has increased by 138.99% in one year.
Market Cap
53.77M
Enterprise Value
37.17M
1-Year Change
138.99%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $53.77M, an increase of 616.98%. That is a compound annual growth rate of 10.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 64.40M | 89.41% |
| Dec 29, 2023 | 34.00M | 112.50% |
| Dec 30, 2022 | 16.00M | -60.59% |
| Dec 31, 2021 | 40.60M | -27.24% |
| Dec 31, 2020 | 55.80M | 164.45% |
| Dec 31, 2019 | 21.10M | 185.14% |
| Dec 31, 2018 | 7.40M | -65.90% |
| Dec 29, 2017 | 21.70M | 233.85% |
| Dec 30, 2016 | 6.50M | 3.17% |
| Dec 31, 2015 | 6.30M | -73.08% |
| Dec 31, 2014 | 23.40M | 10.38% |
| Dec 31, 2013 | 21.20M | -38.19% |
| Dec 31, 2012 | 34.30M | 190.68% |
| Dec 30, 2011 | 11.80M | 247.06% |
| Dec 31, 2010 | 3.40M | -97.92% |
| Dec 31, 2009 | 163.20M | 1,484.47% |
| Dec 31, 2008 | 10.30M | -56.90% |
| Dec 31, 2007 | 23.90M | -22.90% |
| Dec 29, 2006 | 31.00M | -30.49% |
| Dec 30, 2005 | 44.60M | 494.67% |
View and export this data all the way back to 2005.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VolitionRx | 61.25M |
| Entera Bio | 61.14M |
| Xtant Medical Holdings | 60.59M |
| Immuneering | 60.49M |
| Boundless Bio | 60.21M |
| Agenus | 59.23M |
| Mural Oncology | 57.39M |
| DBV Technologies | 57.12M |